These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31948295)

  • 21. The FGF21 Receptor Signaling Complex: Klothoβ, FGFR1c, and Other Regulatory Interactions.
    Kilkenny DM; Rocheleau JV
    Vitam Horm; 2016; 101():17-58. PubMed ID: 27125737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF19 and FGF21: In NASH we trust.
    Talukdar S; Kharitonenkov A
    Mol Metab; 2021 Apr; 46():101152. PubMed ID: 33383173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.
    Díaz-Delfín J; Hondares E; Iglesias R; Giralt M; Caelles C; Villarroya F
    Endocrinology; 2012 Sep; 153(9):4238-45. PubMed ID: 22778214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study.
    Charles ED; Neuschwander-Tetri BA; Pablo Frias J; Kundu S; Luo Y; Tirucherai GS; Christian R
    Obesity (Silver Spring); 2019 Jan; 27(1):41-49. PubMed ID: 30520566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BetaKlotho is required for metabolic activity of fibroblast growth factor 21.
    Ogawa Y; Kurosu H; Yamamoto M; Nandi A; Rosenblatt KP; Goetz R; Eliseenkova AV; Mohammadi M; Kuro-o M
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7432-7. PubMed ID: 17452648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
    Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
    Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.
    Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD
    Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
    Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
    J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH).
    Roberts SK; Majeed A
    Expert Opin Ther Targets; 2021 Oct; 25(10):889-895. PubMed ID: 34727818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma.
    Ocker M
    World J Gastroenterol; 2020 Jan; 26(3):279-290. PubMed ID: 31988589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in
    Hansen AMK; Vienberg SG; Lykkegaard K; Zhao X; Tingqing G; Han D; Zhang X; Thøgersen H; Sass-Ørum K; Tagmose T; Raun K; Andersen B
    Biochem J; 2018 Sep; 475(18):2985-2996. PubMed ID: 30127091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structures of ligand-occupied β-Klotho complexes reveal a molecular mechanism underlying endocrine FGF specificity and activity.
    Kuzina ES; Ung PM; Mohanty J; Tome F; Choi J; Pardon E; Steyaert J; Lax I; Schlessinger A; Schlessinger J; Lee S
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7819-7824. PubMed ID: 30944224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy.
    Zhu S; Wu Y; Ye X; Ma L; Qi J; Yu D; Wei Y; Lin G; Ren G; Li D
    Mol Cell Biochem; 2016 Sep; 420(1-2):107-19. PubMed ID: 27435856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
    Cui G; Martin RC; Jin H; Liu X; Pandit H; Zhao H; Cai L; Zhang P; Li W; Li Y
    J Exp Clin Cancer Res; 2018 Jul; 37(1):136. PubMed ID: 29973237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signaling.
    Shi SY; Lu YW; Richardson J; Min X; Weiszmann J; Richards WG; Wang Z; Zhang Z; Zhang J; Li Y
    Sci Rep; 2018 Jul; 8(1):11045. PubMed ID: 30038432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The FGF metabolic axis.
    Li X
    Front Med; 2019 Oct; 13(5):511-530. PubMed ID: 31495905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL/6J mice.
    Rusli F; Deelen J; Andriyani E; Boekschoten MV; Lute C; van den Akker EB; Müller M; Beekman M; Steegenga WT
    Sci Rep; 2016 Jul; 6():30484. PubMed ID: 27470139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Fibroblast Growth Factor 21 Is Markedly Decreased following Exercise Training in Patients with Biopsy-Proven Nonalcoholic Steatohepatitis.
    Stine JG; Welles JE; Keating S; Hussaini Z; Soriano C; Heinle JW; Geyer N; Chinchilli VM; Loomba R; Kimball SR
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast Growth Factor-Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications.
    Jin L; Yang R; Geng L; Xu A
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():359-382. PubMed ID: 36100222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ascorbic acid attenuates cell stress by activating the fibroblast growth factor 21/fibroblast growth factor receptor 2/adiponectin pathway in HepG2 cells.
    Gu X; Luo X; Wang Y; He Z; Li X; Wu K; Zhang Y; Yang Y; Ji J; Luo X
    Mol Med Rep; 2019 Sep; 20(3):2450-2458. PubMed ID: 31322211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.